Eliminating device tax could boost R&D investment in diabetes therapy

04/2/2014 | Hill, The

Diabetes treatment has substantially improved in recent years, thanks to the development of glucose monitors, patch pumps and other innovative devices, writes Consumers' Research Executive Director Joe Colangelo. These advances, however, are being stifled by the medical device tax. "Reducing or eliminating the medical device tax ... will increase the money that diabetes-focused companies are able to invest into future research," he writes.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC